Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More

Selleck Chemical LLC Crizotinib hydrochloride S5190-5mg
SDP

Catalog No. 502173155
Encompass_Preferred

Crizotinib (PF-02341066) hydrochloride (Xalkori) inhibits tyrosine phosphorylation of c-Met and nucleophosmin (NPM)-anaplastic lymphoma kinase (ALK) with IC50 of of 11 nM and 24 nM in cell-based assays respectively Crizotinib hydrochloride is also a potent ROS1 inhibitor with Ki less than 0 025 nM Crizotinib induces autophagy through inhibition of the STAT3 pathway in multiple lung cancer cell lines

Catalog No. 50-217-3155 Supplier Selleck Chemical LLC Supplier No. S51905MG
May include imposed supplier surcharges.
Add to Cart
Add to Cart

missing translation for 'validMainframeMsg'

Crizotinib (PF-02341066) hydrochloride (Xalkori) inhibits tyrosine phosphorylation of c-Met and nucleophosmin (NPM)-anaplastic lymphoma kinase (ALK) with IC50 of of 11 nM and 24 nM in cell-based assays respectively Crizotinib hydrochloride is also a potent ROS1 inhibitor with Ki less than 0 025 nM Crizotinib induces autophagy through inhibition of the STAT3 pathway in multiple lung cancer cell lines

Product Title
Select an issue

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.